Dr. Reddy's Laboratories

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com.

Registered Company Name	DR.REDDY'S LABORATORIES LTD
Active/Inactive	Active
CIN	L85195TG1984PLC004507
Headquater	Hyderabad, Telangana, India
Office Location	Hyderabad, Telangana, India
Incorporation Year	1986(38 yrs old)
Industry	Pharmaceuticals
Company Employees	10000+
Website	https://www.drreddys.com/
Phone Number	+91 40 4900 2900
Social Profile